ANI Pharmaceuticals (ANIP)

[LordDarley]

For the record:

1.I never recommended investment in MNK. On April 8, 2020 I advised I was buying at $2/share for a short term flutter because I saw the possibility of a short squeeze. Very quickly, the stock was at $3. I got a few claps and advised the Board in late April that I was out of it. Just a succesful trade in a very troubled company.

2.Am I still worried about MNK (or a later purchaser or co-venturere) and Acthar? You bet. MNK investors were destroyed, but the management is still there and very smart. I think they have 10% of the company now without putting up any cash and getting great incentives to stay during the bankruptcy process. I've posted before why this post-bankruptcy MNK has some advantages ANIP does not, so I'll leave it there. This does not mean that ANIP won't make a lot of money with Corti, but Acthar, with more testing behind some of its label indications, a conversion to subscription pricing, and a bigger marketing force is real competition.

3. Conspiracy theories? Yup. Let's not debate that.